Quinoline compounds

Abstract

There are disclosed compounds of the formula ##STR1## wherein X is N or CR.sup.1 Y is O, S, NR.sup.1, CHR.sup.1 or C(R.sup.1).sub.2 when n=O, or N or CR.sup.1 when n=1; p is 0-3; R.sup.1 is hydrogen or lower alkyl; R.sup.2 is H, ##STR2## --SO.sub.2 R.sup.3 or --SO.sub.2 N(R.sup.3).sub.2, lower alkyl, lower alkenyl, lower alkynyl or lower alkyl carbonyl prolinate; R.sup.3 is H, lower alkyl or perfluoro lower alkyl; R.sup.4 is lower alkyl, phenyl, pyridyl or thienyl; R.sup.5 is hydrogen, lower alkyl, phenyl or pyridyl; A is O or NR.sup.1 ; B is OR.sup.1 or N(R.sup.5).sub.2 ; m is 0-2; and the pharmaceutically acceptable salts thereof, and their use in the treatment of leukotriene-mediated naso-bronchial obstructive airpassageway conditions, such as allergic rhinitis, allergic bronchial asthma and the like.

Dependencies are inferred from the claim text.